miR-210-3p maintains sustained NF-κB signaling by targeting its negative regulators TNIP1 (TNF-α-induced protein-3 interaction protein 1) and SOCS1 (cytokine signal transduction inhibitor 1) and leading to cancer cell migration and establishment of bone metastasis. This evidence concerns the gene NFKB1 and cancer.